[HTML][HTML] Pharmacokinetic/pharmacodynamic modelling of allopurinol, its active metabolite oxypurinol, and biomarkers hypoxanthine, xanthine and uric acid in hypoxic …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - Clinical … - Springer
Background Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention that
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
[PDF][PDF] Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - 2021 - scholar.archive.org
BACKGROUND Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad… - Clinical …, 2022 - search.ebscohost.com
Background: Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention that
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad, M Metsäranta… - 2022 - helda.helsinki.fi
Background: Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention that
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - Clinical …, 2022 - zora.uzh.ch
BACKGROUND Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - Clinical …, 2022 - diva-portal.org
BACKGROUND: Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
that may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
[HTML][HTML] Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in …
WY Chu, KV Annink, AL Nijstad… - Clinical …, 2022 - ncbi.nlm.nih.gov
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol,
and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy …
and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy …
[引用][C] Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in …
WY Chu, KV Annink, AL Nijstad… - Clinical …, 2022 - tobias-lib.ub.uni-tuebingen.de
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol,
and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy …
and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention that
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic …
WY Chu, KV Annink, AL Nijstad, CA Maiwald… - Clinical …, 2021 - europepmc.org
Background Allopurinol, an xanthine oxidase (XO) inhibitor, is a promising intervention that
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …
may provide neuroprotection for neonates with hypoxic-ischemic encephalopathy (HIE) …